Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dikang Chen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|May 19, 2018
A signature based on survival-related genes identifies high-risk glioblastomas harboring immunosuppressive and aggressive ECM characteristicsDi Chen, Dikang Chen, Dongqing Cao, et al.
Biosensors|September 26, 2025
Deep Learning-Driven Multimodal Integration of miRNA and Radiomic for Lung Cancer DiagnosisYuanyuan Chen, Dikang Chen, Xiaohui Liu, et al.
Cell Death & Disease|August 18, 2022
Whole transcriptome and proteome analyses identify potential targets and mechanisms underlying tumor treating fields against glioblastomaShengchao Xu, Chengke Luo, Dikang Chen, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 18, 2023
circMMD reduction following tumor treating fields inhibits glioblastoma progression through FUBP1/FIR/DVL1 and miR-15b-5p/FZD6 signalingShengchao Xu, Chengke Luo, Dikang Chen, et al.
Cell Death Discovery|October 11, 2022
The schemes, mechanisms and molecular pathway changes of Tumor Treating Fields (TTFields) alone or in combination with radiotherapy and chemotherapyGuilong Tanzhu, Liu Chen, Gang Xiao, et al.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|June 12, 2015
[Up-regulation of TIM-3 on CD4+ tumor infiltrating lymphocytes predicts poor prognosis in human non-small-cell lung cancer]Peng Ji, Dikang Chen, Jianye Bian, et al.
Clinical Medicine Insights. Oncology|July 15, 2025
Cisplatin and Alternating Temozolomide in Recurrent High-Grade Gliomas: Efficacy and the Role of Tumor-Infiltrating Lymphocytes in a Phase II Clinical TrialXiaojie Ding, Di Chen, Zhenyu Zhang, et al.
CNS Neuroscience & Therapeutics|August 1, 2020
Evaluation of a tumor electric field treatment system in a rat model of gliomaHao Wu, Chenxi Wang, Jialin Liu, et al.
Computer Methods and Programs in Biomedicine|November 9, 2024
Prediction of intracranial electric field strength and analysis of treatment protocols in tumor electric field therapy targeting gliomas of the brainJun Wen, Lingzhi Xiong, Shulu Wang, et al.
Journal of Neuro-Oncology|September 13, 2018
The prognostic value of maximal surgical resection is attenuated in oligodendroglioma subgroups of adult diffuse glioma: a multicenter retrospective studyXiaojie Ding, Zheng Wang, Di Chen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|May 19, 2018
A signature based on survival-related genes identifies high-risk glioblastomas harboring immunosuppressive and aggressive ECM characteristicsDi Chen, Dikang Chen, Dongqing Cao, et al.
Biosensors|September 26, 2025
Deep Learning-Driven Multimodal Integration of miRNA and Radiomic for Lung Cancer DiagnosisYuanyuan Chen, Dikang Chen, Xiaohui Liu, et al.
Cell Death & Disease|August 18, 2022
Whole transcriptome and proteome analyses identify potential targets and mechanisms underlying tumor treating fields against glioblastomaShengchao Xu, Chengke Luo, Dikang Chen, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 18, 2023
circMMD reduction following tumor treating fields inhibits glioblastoma progression through FUBP1/FIR/DVL1 and miR-15b-5p/FZD6 signalingShengchao Xu, Chengke Luo, Dikang Chen, et al.
Cell Death Discovery|October 11, 2022
The schemes, mechanisms and molecular pathway changes of Tumor Treating Fields (TTFields) alone or in combination with radiotherapy and chemotherapyGuilong Tanzhu, Liu Chen, Gang Xiao, et al.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|June 12, 2015
[Up-regulation of TIM-3 on CD4+ tumor infiltrating lymphocytes predicts poor prognosis in human non-small-cell lung cancer]Peng Ji, Dikang Chen, Jianye Bian, et al.
Clinical Medicine Insights. Oncology|July 15, 2025
Cisplatin and Alternating Temozolomide in Recurrent High-Grade Gliomas: Efficacy and the Role of Tumor-Infiltrating Lymphocytes in a Phase II Clinical TrialXiaojie Ding, Di Chen, Zhenyu Zhang, et al.
CNS Neuroscience & Therapeutics|August 1, 2020
Evaluation of a tumor electric field treatment system in a rat model of gliomaHao Wu, Chenxi Wang, Jialin Liu, et al.
Computer Methods and Programs in Biomedicine|November 9, 2024
Prediction of intracranial electric field strength and analysis of treatment protocols in tumor electric field therapy targeting gliomas of the brainJun Wen, Lingzhi Xiong, Shulu Wang, et al.
Journal of Neuro-Oncology|September 13, 2018
The prognostic value of maximal surgical resection is attenuated in oligodendroglioma subgroups of adult diffuse glioma: a multicenter retrospective studyXiaojie Ding, Zheng Wang, Di Chen, et al.
Pageof 2